🌍 Market Insights

The Future of Oncology Access

Cancer incidence in Africa and Asia is rising faster than anywhere else in the world.
Yet most hospitals lack access to affordable, high-quality medicines.
This creates one of the biggest healthcare supply gaps of our time — and one of the strongest business opportunities for producers.

Data Snapshot (GLOBOCAN 2022):

• Africa: +1.1 million new cancer cases annually (projected to double by 2040).

• Asia: +9.5 million new cancer cases annually (60% of global total).

• Europe: market saturated, low growth (<2% per year).

The next decade belongs to producers who act now — those who bridge innovation with access.

Why Africa and Asia Matter

• Growing population = growing need for oncology care.

• Governments expanding national cancer programs.

• Hospitals looking for EU-quality medicines and partners they can trust.